Letter: Evolving Clinical Evidence: Electroencephalography Abnormalities in Autism Spectrum Disorder and the Emerging Role of Neuroelectric Biomarkers in Psychiatry
Restricted accessLetterFirst published online November, 2025
Letter: Evolving Clinical Evidence: Electroencephalography Abnormalities in Autism Spectrum Disorder and the Emerging Role of Neuroelectric Biomarkers in Psychiatry
ChezMG, ChangM, KrasneV, et al.Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav, 2006; 8(1):267–271; doi: 10.1016/j.yebeh.2005.11.001
2.
MilovanovicM, GrujicicR. Electroencephalography in assessment of autism spectrum disorders: A review. Front Psychiatry, 2021; 12:686021; doi: 10.3389/fpsyt.2021.686021
3.
SpenceSJ, SchneiderMT. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res, 2009; 65(6):599–606; doi: 10.1203/PDR.0b013e31819e7168
4.
SwatzynaRJ, MorrowLM, CollinsDM, et al.Evidentiary significance of routine EEG in refractory cases: A paradigm shift in psychiatry. Clin EEG Neurosci, 2024:15500594231221313; doi: 10.1177/15500594231221313
5.
ThomRP, WarrenTL, KhanS, et al.A blueprint for translational precision medicine in autism spectrum disorder and related neurogenetic syndromes. J Child Adolesc Psychopharmacol, 2025; 35(4):178–193; doi: 10.1089/cap.2025.0023
